BenzingaBenzinga Japan
BenzingaBenzinga Japan
BenzingaBenzinga Japan
日曜日, 9 13

AEON Biopharma Inc

AEONAMEX
Trade with Public
Trade with Public
$0.3269
0.036912.72%
近くで: Sep 11, 5:00 PM EST
$0.3100
-0.0169-5.17%
時間外: Sep 11, 7:59 PM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較株式レポート

AEON Biopharma Earnings & Forecasts

AEON Biopharma (AEON) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

AEON Biopharma Guidance

Recent Earnings Results

MetricQ2 '26Q1 '26Q4 '25Q3 '25
Earnings Per Share (Non-GAAP)
Estimate$-0.33$-0.44$-0.26$-0.43
Actual$-0.02$-0.29$-3.72$-0.39
Surprise+93.9%+34.1%-1330.8%+9.30%
Revenue
Estimate————
Actual$0$0$0$0
Surprise————
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
MetricQ3 '26EQ4 '26EQ1 '27EQ2 '27E
Earnings Per Share (Non-GAAP)
Consensus$-0.08$-0.09$-0.09$-0.06
Revenue
Consensus————
More with Benzinga EdgeGet Access

Earnings & Guidance News

PRO
AEON Biopharma Q2 EPS $(0.02) Beats $(0.12) Estimate

AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.12) by 83.33 percent. This is a 96.67 percent increase over losses of $(0.60) per share from the
Benzinga Newsdesk

PRO
AEON Biopharma Q1 EPS $(0.29) Misses $(0.13) Estimate

AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.13) by 141.67 percent. This is a 112.72 percent decrease over earnings of $2.28 per share from
Benzinga Newsdesk

PRO
AEON Biopharma Q4 EPS $(3.72)

AEON Biopharma (AMEX:AEON) reported quarterly losses of $(3.72) per share. This is a 199.2 percent decrease over earnings of $3.75 per share from the same period last year.
Benzinga Newsdesk

PRO
AEON Biopharma Q3 EPS $(0.39) Beats $(0.43) Estimate

AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.43) by 9.3 percent. This is a 96.61 percent increase over losses of $(11.52) per share from the
Benzinga Newsdesk

PRO
AEON Biopharma Q2 EPS $(0.60) Beats $(11.52) Estimate

AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(11.52) by 94.79 percent. This is a 100.2 percent decrease over earnings of $304.00 per share from
Benzinga Newsdesk

PRO
AEON Biopharma Q1 EPS $2.28 Up From $(227.87) YoY

Benzinga Newsdesk

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

BenzingaBenzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved